Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
124M
-
Number of holders
-
379
-
Total 13F shares, excl. options
-
92.1M
-
Shares change
-
-1.97M
-
Total reported value, excl. options
-
$9.21B
-
Value change
-
-$251M
-
Put/Call ratio
-
0.55
-
Number of buys
-
173
-
Number of sells
-
-182
-
Price
-
$100.02
Significant Holders of Guardant Health, Inc. - Common Stock (GH) as of Q4 2021
463 filings reported holding GH - Guardant Health, Inc. - Common Stock as of Q4 2021.
Guardant Health, Inc. - Common Stock (GH) has 379 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 92.1M shares
of 124M outstanding shares and own 74.35% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8.76M shares), Capital Research Global Investors (7.93M shares), FMR LLC (7.46M shares), MORGAN STANLEY (5.82M shares), BlackRock Inc. (5.11M shares), VIKING GLOBAL INVESTORS LP (5.07M shares), Clearbridge Investments, LLC (3.11M shares), Capital International Investors (2.97M shares), Nuveen Asset Management, LLC (2.01M shares), and CREDIT SUISSE AG/ (1.81M shares).
This table shows the top 379 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.